Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Galderma
(https://galderma.com) 📸 Data Snapshot: May 30, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE Galderma: Advancing dermatology for every skin story (https://galderma.com)
Galderma: Advancing dermatology for every skin story
Galderma
NAV_HEADER_HEADING_REPEATED_BODY OUR BRANDS | Galderma (https://galderma.com/our-brands/)
OUR BRANDS | Galderma
NAV_HEADER_HEADING_REPEATED_BODY CAREERS | Galderma (https://galderma.com/careers/)
CAREERS | Galderma
NAV_HEADER_HEADING_REPEATED Benelux | Galderma (https://galderma.com/benelux/)
Benelux | Galderma
Country page for Benelux.
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://galderma.com) Galderma: Advancing dermatology for every skin story
[H1] Advancing dermatology for every skin story Everyone's skin is unique and we each have our own skin story. At Galderma, we embrace these differences and offer cutting-edge, premium brands that fit people's individual needs, across the full spectrum of dermatology through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. LEARN MORE [IMG: Galderma 2026_012] [IMG: Galderma 01_01] Play video Your browser does not support HTML5 video. [H2] BRINGING INNOVATION TO LIFE [IMG: A blonde woman working in the laboratory holding test probes] Learn more [H2] MANUFACTURING [IMG: _MG_2621-Modifier(580x268).jpg] Learn more [H2] SHARING SKIN STORIES [IMG: Skin Galderma 2026 01] [H2] SKIN STORIES Meet some people who have shared with us their unique skin stories. Their stories—and yours—and yours - remind us every day why we do what we do. We embrace these differences – every skin story is important to us. LEARN MORE 22 . 05 . 2026Press releaseGalderma receives U.S. FDA approval for Differin® Epiduo® Acne Gel Prescription-to-OTC switch See all news [IMG: Medication driven weight loss report cover 2 940x434] Galderma's response to aesthetic impact of medication-driven weight loss ACCESS THE REPORT FUNDING REQUESTS [IMG: A scientist wearing a facemask and a headcap looking into a monitor] GOVERNANCE OVERSIGHT [IMG: Doctor sitting in a chair and listening to his patient] SUSTAINABILITY CAREERS [H2] Our Brands Discover the brands that make up the Galderma portfolio. [IMG: Relfydess] [IMG: Nemluvio] [IMG: TRI-LUMA] [IMG: Actinica] [IMG: Aklief] [IMG: ALASTIN] [IMG: Alluzience] [IMG: Dysport] [IMG: Sculptra] [IMG: Restylane Skinboosters] [IMG: Differin] [IMG: Metvix] [IMG: Epiduo Forte] [IMG: Soolantra] [IMG: Mirvaso] [IMG: Oracea] [IMG: Epiduo] [IMG: Benzac] [IMG: Cetaphil] [IMG: Azzalure] [IMG: Restylane] [IMG: Loceryl] All brands [H2] Confirm navigation You are about to leave the Galderma global site. Are you sure you want to leave this page?
SUB-PAGE (https://galderma.com/our-brands/) OUR BRANDS | Galderma
We offer a synergistic portfolio of flagship brands with leading market positions in their respective product categories, supported by science-based product differentiation and premium positioning.If you would like to find more information about our products, please visit our document Library for detailed instructions for use (IFUs) and additional resources.Our innovative product range includes the following sophisticated brands: [IMG: ALASTIN] Close [H2] ALASTIN [H2] ALASTIN Type PROFESSIONAL SKINCARE: PERI-PROCEDURAL AND DAILY REGIMENS ALASTIN Skincare® is the complete rejuvenation approach to support skin’s appearance following aesthetic procedures and to restore skin health on a daily basis—our science-centered formulations help patients on their journey to achieving skin that looks healthier and more youthful.Backed by scientific proof and clinical evidence with over 25 published clinical studies. Our team includes leading scientists and formulators who have a deep understanding of the science related to the functioning of the skin, and decades of experience creating unique and synergistic formulations.Clinically Tested. Scientifically Proven.Cruelty-Free, Paraben-Free, Gluten-Free [IMG: Actinica] Close [H2] Actinica [H2] Actinica Type Prescription ACTINICA® Lotion offers a very broad spectrum of protection against the UV rays of the sun. It is used to reduce the risk of skin cancer in people who may be at high risk. [IMG: Aklief] Close [H2] Aklief [IMG: Aklief] [H2] Aklief Type Prescription & Acne In the European Union, AKLIEF® (trifarotene 50 mcg/g cream) is indicated for the cutaneous treatment of acne vulgaris of the face and/or the trunk in patients from 12 years of age and older, when many comedones, papules and pustules are present. [H4] [H4] Product shown may not be available in all countries or may be known by a different name. Indications for use may vary from country to country. Therefore, please always refer to the product information approved in your country. [IMG: Alluzience] Close [H2] Alluzience [IMG: Alluzience] [H2] Alluzience Type Aesthetic & Corrective & Aging skin ALLUZIENCE® is the first ready-to-use liquid botulinum toxin type A in Europe, available as a treatment to temporarily improve the appearance of moderate to severe glabellar lines. [H4] Product shown may not be available in all countries or may be known by a different name. Indications for use may vary from country to country. Therefore, please always refer to the product information approved in your country. [IMG: Azzalure] Close [H2] Azzalure [IMG: Azzalure] [H2] Azzalure Type Aesthetic & Corrective & Aging skin Azzalure® is a local muscle relaxant adapted from the botulinum neuromodulator type-A of Dysport® and is specifically designed for use in aesthetic indications. [H4] Product shown may not be available in all countries or may be known by a different name. Indications for use may vary from country to country. Therefore, please always refer to the product information approved in your country. [IMG: Benzac] Close [H2] Benzac [IMG: Benzac] [H2] Benzac Type Consumer solutions & Acne Benzac is a range of dermatological products for the effective treatment and management of acne. The complete range includes: treatments, cleansers, moisturisers and scrubs. [H4] [H4] Product shown may not be available in all countries or may be known by a different name. Indications for use may vary from country to country. Therefore, please always refer to the product information approved in your country. [IMG: Cetaphil] Close [H2] Cetaphil [IMG: Cetaphil] [H2] Cetaphil Type Consumer solutions & Sensitive skin Cetaphil encompasses a range of cleansing moisturizing and UV protective products for compromised and sensitive skin. Cetaphil is a premium skincare brand that has been recommended by dermatologists for over 70 years, and is today used by millions of people with sensitive skin from all over the world. [IMG: Differin] Close [H2] Differin [IMG: Differin] [H2] Differin Type Prescription & Acne Differin is a topical retinoid containing adapalene 0.1% or 0.3%. It works inside pilosebaceous units to control some of the causes of the build-up that leads to the formation of acne lesions. Differin normalizes the improper accumulation of skin cells (keratinocytes) that plug the pores, and effectively keeps them clear and decreases the local inflammation. [H4] [H4] Product shown may not be available in all countries or may be known by a different name. Indications for use may vary from country to country. Therefore, please always refer to the product information approved in your country. [IMG: Dysport] Close [H2] Dysport [IMG: Dysport] [H2] Dysport Type Aesthetic & Corrective & Aging skin Dysport is a local muscle relaxant (or neuromuscular blocking agent) adapted from the botulinum neuromodulator type-A and is used in aesthetic indications. [H4] Product shown may not be available in all countries or may be known by a different name. Indications for use may vary from country to country. Therefore, please always refer to the product information approved in your country. [IMG: Epiduo] Close [H2] Epiduo [H2] Epiduo Type Prescription & Acne Indication: Epiduo® 0.1% / 2.5% gel is indicated for the cutaneous treatment of Acne vulgaris when comedones, papules and pustules are present. [H4] [H4] Product shown may not be available in all countries or may be known by a different name. Indications for use may vary from country to country. Therefore, please always refer to the product information approved in your country. [IMG: Epiduo Forte] Close [H2] Epiduo Forte [H2] Epiduo Forte Type Prescription & Acne Indication: Epiduo® Forte 0.3% / 2.5% gel is indicated for the cutaneous treatment of Acne vulgaris, when comedones, numerous papules and pustules are present. [H4] [H4] Product shown may not be available in all countries or may be known by a different name. Indications for use may vary from country to country. Therefore, please always refer to the product information approved in your country. [IMG: Loceryl] Close [H2] Loceryl [IMG: Loceryl] [H2] Loceryl Type Consumer solutions & Onychomycosis Loceryl Nail Lacquer Loceryl Nail Lacquer is an antifungal for the treatment of onychomycosis. The active ingredient is amorolfine. [H4] [H4] Product shown may not be available in all countries or may be known by a different name. Indications for use may vary from country to country. Therefore, please always refer to the product information approved in your country. [IMG: Metvix] Close [H2] Metvix [H2] Metvix Type Prescription & Actinic keratosis (AK) Metvix® is a topical photosensitizer containing 16% methyl aminolevulinate available in tubes containing 2g of cream for use in photodynamic therapy. Metvix® is indicated for the treatment of actinic keratosis, superficial and/or nodular basal cell carcinoma as well as Bowen’s disease. Metvix® should be administered in the presence of a physician, a nurse or other health care professional trained in the use of photodynamic therapy. [H4] [H4] Product shown may not be available in all countries or may be known by a different name. Indications for use may vary from country to country. Therefore, please always refer to the product information approved in your country. [IMG: Mirvaso] Close [H2] Mirvaso [IMG: Mirvaso] [H2] Mirvaso Type Prescription & Facial rosacea Mirvaso 0.5% gel (brimonidine) 3 mg/g gel is indicated for the symptomatic treatment of facial erythema of rosacea in adult patients. [H4] [H4] Product shown may not be available in all countries or may be known by a different name. Indications for use may vary from country to country. Therefore, please always refer to the product information approved in your country. [IMG: Nemluvio] Close [H2] Nemluvio [H2] Nemluvio Type Prescription NEMLUVIO® (nemolizumab) is a monoclonal antibody.NEMLUVIO is a prescription medicine.Product may not be available in all countries or may be known by a different name. Indications for use may vary from country to country. Therefore, please always refer to the product information approved in your country. [IMG: Oracea] Close [H2] Oracea [IMG: Oracea] [H2] Oracea Type Prescription & Facial rosacea Oracea® 40 mg modified-release hard capsule is indicated to reduce papulopustular lesions in adult patients with facial rosacea. [H4] [H4] Product shown may not be available in all countries or may be known by a different name. Indications for use may vary from country to country. Therefore, please always refer to the product information approved in your country. [IMG: Relfydess] Close [H2] Relfydess [H2] Relfydess Type Aesthetic & Corrective & Aging skin Relfydess® (RelabotulinumtoxinA) is the first and only ready-to-use liquid neuromodulator created with PEARLTM Technology, developed and manufactured by Galderma. Relfydess® is indicated for the temporary improvement in the appearance of moderate-to-severe glabellar lines and lateral canthal lines. Product shown may not be available in all countries or may be known by a different name. Indications for use may vary from country to country. Therefore, please always refer to the product information approved in your country. [IMG: Restylane] Close [H2] Restylane [IMG: Restylane] [H2] Restylane Type Aesthetic & Corrective & Aging skin Restylane® is a range of hyaluronic acid-based products consisting of two product groups: Restylane fillers and, Restylane Skinboosters. [IMG: Restylane Skinboosters] Close [H2] Restylane Skinboosters [IMG: Restylane Skinboosters] [H2] Restylane Skinboosters Type Aesthetic & Corrective & Aging skin A fresh approach to skin rejuvenation, designed to deliver hydration and improvements to skin imperfections resulting in radiant healthy skin. Learn and discover more about Restylane Skinboosters®. [H4] Product shown may not be available in all countries or may be known by a different name. Indications for use may vary from country to country. Therefore, please always refer to the product information approved in your country. [IMG: Sculptra] Close [H2] Sculptra [IMG: Sculptra] [H2] Sculptra Type Aesthetic & Corrective & Aging skin Sculptra® – the treatment that activates your skin’s natural power to revitalize collagen production for a more youthful appearance. Sculptra is a unique aesthetic treatment due to its ability to stimulate collagen. [H4] Product shown may not be available in all countries or may be known by a different name. Indications for use may vary from country to country. Therefore, please always refer to the product information approved in your country. [IMG: Soolantra] Close [H2] Soolantra [IMG: Soolantra] [H2] Soolantra Type Prescription & Facial rosacea Soolantra® 10 mg/g cream is indicated for the topical treatment of inflammatory lesions of rosacea (papulopustular) in adult patients. [H4] Product shown may not be available in all countries or may be known by a different name. Indications for use may vary from country to country. Therefore, please always refer to the product information approved in your country. [IMG: TRI-LUMA] Close [H2] TRI-LUMA [IMG: Triluma] [H2] TRI-LUMA Type Consumer solutions & Acne TRI-LUMA® Cream is a combination of fluocinolone acetonide (a corticosteroid), hydroquinone (a melanin synthesis inhibitor), and tretinoin (a retinoid) that is indicated for the short-term treatment of moderate-to-severe melasma of the face in the presence of measures for sun avoidance, including the use of sunscreens. [H4] Products shown may not be available in all countries or may be known by a different name. Indications for use may vary from country to country. Therefore, please always refer to the product information approved in your country. SEE ALSO [H3] INNOVATION [IMG: Woman] [H3] SKIN STORIES [IMG: Blonde woman looking into the mirror examining her skin] [H2] Confirm navigation You are about to leave the Galderma global site. Are you sure you want to leave this page?
SUB-PAGE (https://galderma.com/careers/) CAREERS | Galderma
Galderma is the only truly scaled pure-play dermatology company. Our 40+ year heritage in dermatology; premium portfolio of brands and services; and positioning in attractive market segments underpin our central ambition: to advance our category leadership in dermatology. Together, we strive to meet individual consumer and patient needs with superior outcomes. [H3] WE’RE LEADING THE WAY. REALIZE YOUR POTENTIAL. VIEW OUR OPPORTUNITIES We are unique in our ability to offer the broadest range of clinically proven skin treatments to patients through the course of their lives, whatever their skin story. Every team and every individual has a role to play as we work to remain at the forefront of dermatological innovation. [IMG: Faces of galderma] Play video WE ARE UNIFIED BY A COMMON PURPOSEGalderma’s purpose is ‘Advancing dermatology for every skin story.’ This purpose reflects the understanding that we have the power and responsibility to enhance both physical and mental well-being by using our dermatological expertise to help people maintain healthy skin and embrace their unique and authentic selves.We focus on scientific innovation, and are committed to finding solutions to meet the diverse skin needs of patients and consumers across the globe.Grow with us [IMG: Our purpose] Play video OUR COMMITMENTSWe listen to consumers, patients and customers, always putting their needs first. We innovate to stay at the cutting edge, embracing our heritage in dermatology. We collaborate openly to empower each other and our partners. We rise above expectations to achieve outstanding results. As we work together to grow as individuals and as a company, we encourage our people to uphold these four commitments. Join our journey [IMG: our commitements] Play video WE EMBRACE DIVERSITY AND INCLUSION Galderma is a diverse and inclusive workplace where different ideas can flourish and translate into real business outcomes. We insist on respecting the dignity, privacy and personal rights of every employee. We expect our employees and business partners to extend the same respect to each other as well as to patients and consumers. At Galderma, we celebrate differences – whether among our people, our customers or the patients and consumers we serve. Make your mark [IMG: we embrace diversity] Play video WE WORK TOGETHER TO MAKE THINGS HAPPENWe seek bold and sophisticated talent with the capacity to innovate, collaborate and execute across teams and geographies to deliver outstanding results. Hear from our people around the globe in our Dallas (U.S.), Zug (Switzerland), Singapore and Uppsala (Sweden) offices about what working at Galderma is really like. [H2] At Galderma, each individual brings their own distinctive skills, ideas and passions to the table as we collaborate to improve quality of life for people with a variety of skin needs. [IMG: Courtney_Dallas] [H3] OUR PEOPLE MAKE A DIFFERENCE We value what every member of our team brings and foster a high-performance culture where people can thrive and excel at what they do. Our cultureAt Galderma, we value the unique skills and perspectives offered by every individual, and we make sure that every voice is heard and valued.Read more A common purposeAt Galderma, we share a common purpose: Advancing dermatology for every skin story. We all share a dedication to impacting the lives of patients and consumers for the better.Read more Collaborative growthWe’ve established ourselves as a transformative and global industry leader. Our success is deeply intertwined with the experiences and perspectives of our people.Read more Making an impactWe encourage people to try new things, take risks and really push themselves. Our premium products and services are the result of continued scientific research.Read more We’re inspired by our peopleWe foster an environment where people are empowered to excel at what they do. If you’re ambitious and driven, there’s no limit to what you can do.Read more An organization built on uniquenessYour skin is unique. Working at Galderma isn’t like anywhere else thanks to or our commitment to valuing the individual contributions of our people.Read more [H2] Our purpose Advancing dermatology for every skin story. Read more [H2] About us At Galderma, we’re committed to delivering premium, cutting-edge dermatology brands, developed through scientific innovation. Read more [H2] Global presence [IMG: Global presence] See our global headquarters, affiliates and other representation. Read more [H2] Latest opportunities To view our current job opportunities, follow the appropriate link below. Read more [H2] Confirm navigation You are about to leave the Galderma global site. Are you sure you want to leave this page?
SUB-PAGE (https://galderma.com/benelux/) Benelux | Galderma
“We will change the way the world thinks about skin health” Dat is de visie van Galderma, een farmaceutisch bedrijf dat zich wererldwijd richt op dermatologie en zich specialiseert in de speciale vaardigheden en competenties die de wereld van de dermatologie met zich meebrengt. We ontwikkelen innovatieve medische en esthetische oplossingen en ondersteunen professionals over de hele wereld met hulp en advies. “We will change the way the world thinks about skin health” C'est la vision de Galderma, une société pharmaceutique qui, dans le monde entier, se concentre sur la dermatologie et est spécialisée dans le savoir-faire, les aptitudes et les compétences intrinsèques au domaine de la dermatologie. Nous développons des solutions médicales et esthétiques innovantes et soutenons les professionnels du monde entier en leur fournissant aide et conseils. De huid is een uniek orgaan van het menselijk lichaam. Het is het grootste orgaan en beschermt het lichaam tegen de buitenwereld. Juist daarom is het belangrijk de huid zorgvuldig en met voldoende aandacht te behandelen. Galderma erkent het belang van de huid alsook de pshychologische en sociale impact van huidaandoeningen op het dagelijks leven van patiënten. Daarom richt Galderma zich al meer dan 30 jaar op het ontwikkelen van innovatieve medische en esthetische oplossingen voor de huid, die aan de eisen van patiënten en hun behandelende artsen voldoen. La peau est un organe unique du corps humain. C’est l’organe le plus grand du corps, qui le protège contre les agressions du monde extérieur. Et c'est précisément pour cette raison qu'il est important de traiter la peau avec le soin et l’attention qu’elle mérite. Galderma reconnaît l'importance de la peau ainsi que l'impact psychologique et social des affections de la peau sur la vie quotidienne des patients. Depuis plus de 30 ans, Galderma se concentre donc sur le développement de solutions médicales et esthétiques innovantes pour la peau, qui répondent aux exigences des patients et de leurs médecins traitants. [H3] GALDERMA BENELUX B.V. Gravinnen van Nassauboulevard 91 4811 BN Breda +31(0)183 69 19 19 info.nl@galderma.com Galderma_VigilancePrivacyNotice002_181002.pdf [H2] Confirm navigation You are about to leave the Galderma global site. Are you sure you want to leave this page?
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 6 | 0 |
| /our-brands/ | 9 | 0 |
| /careers/ | 0 | 0 |
| /benelux/ | 0 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
Based on 784 businesses audited.
Galderma has 5.3 points more BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: Galderma (galderma.com)
Galderma is a legitimate pharmaceutical powerhouse hiding behind a high-gloss corporate marketing veil. While the product substance is undeniable, the site relies heavily on trust theatre and generic ‘science-speak’ rather than providing the granular, cited evidence required for a perfect substance score. It is a site where the brands do the heavy lifting for a technical infrastructure that is surprisingly hollow.
Implement Organization and Person schema to formally link the brand and its unnamed scientists to verifiable digital footprints. Replace the generic star ratings on the Brand page with links to third-party review platforms or published clinical trial results. Add a bibliography or citation section to the Alastin and Sculptra product descriptions that links directly to the 25 published clinical studies mentioned. Remove the generic marketing fluff from the Careers page and replace it with specific workforce data, such as internal promotion rates or diversity percentages.
The website perfectly aligns with the Medical Devices, Pharma & Biotech category. It contains specific pharmacological details, regulatory terminology like FDA approval and prescription indications, and organizes content into therapeutic areas such as Injectable Aesthetics and Therapeutic Dermatology.
“The score of 46 reflects a moderate BS level, primarily driven by Authority Gaps (lack of schema) and Trust Theatre (reviews without verification links). The site's strong Information Density on the Brands page prevented a much higher BS score, as the company clearly possesses the technical and regulatory substance it claims, even if it presents it in a marketing-heavy format.”
This training module utilizes a snapshot of public data from Galderma, captured on May 30, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to Galderma: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://galderma.com to view the most current version of its content and learn from the source what this company is about and what it offers.